- Ozempic set to become more affordable, accessible in Canada — raising concerns of drug abuse CTV News
- Hims & Hers to offer generic semaglutide in Canada as Novo Nordisk patent lapses CNBC
- Citi reiterates Sell rating on Hims and Hers stock as company expands to Canada Investing.com
- Hims & Hers’ Canadian Gamble: Can Generic Semaglutide Unlock a $4 Billion Market? AInvest
- Hims & Hers expands into Canada as generic semaglutide drug market opens up Fierce Healthcare